Pacira Biosciences
PCRX
#6455
Rank
ยฃ0.70 B
Marketcap
ยฃ17.91
Share price
1.50%
Change (1 day)
-2.94%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2026 (TTM): ยฃ9.87 Million

According to Pacira Biosciences 's latest financial reports the company's current earnings are ยฃ0.73 Billion. In 2025 the company made an earning of ยฃ12.4 Million, an increase over its 2024 earnings that were of -ยฃ46.41 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ9.87 M-20.38%
2025 ยฃ12.4 M-126.74%
2024 -ยฃ46.41 Million-202.28%
2023 ยฃ45.37 M363.85%
2022 ยฃ9.78 M-76.42%
2021 ยฃ41.47 M180.76%
2020 ยฃ14.77 M-286.92%
2019 -ยฃ7.91 Million2428.94%
2018 -ยฃ0.32 Million-99%
2017 -ยฃ31.24 Million12.23%
2016 -ยฃ27.83 Million-1885.05%
2015 ยฃ1.55 M-115.65%
2014 -ยฃ9.96 Million-78.95%
2013 -ยฃ47.33 Million21.55%
2012 -ยฃ38.93 Million41.18%
2011 -ยฃ27.58 Million57.4%
2010 -ยฃ17.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Zogenix
ZGNX
-ยฃ0.16 Billion-1,710.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
ยฃ2.76 M-71.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-ยฃ17.76 Million-283.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-ยฃ58.38 Million-702.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-ยฃ22.76 Million-335.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-ยฃ46.18 Million-576.93%๐Ÿ‡บ๐Ÿ‡ธ USA